- Home
- DOYU vs HUMA Comparison
DOYU vs HUMA Comparison
Compare DOYU & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DOYU | HUMA |
|---|---|---|
| Founded | 2014 | 2004 |
| Country | China | United States |
| Employees | N/A | 184 |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 153.0M | 155.4M |
| IPO Year | 2019 | N/A |
Fundamental Metrics
Financial Performance| Metric | DOYU | HUMA |
|---|---|---|
| Price | $4.70 | $1.04 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 8 |
| Target Price | ★ $7.00 | $6.19 |
| AVG Volume (30 Days) | 16.7K | ★ 6.2M |
| Earning Date | 05-19-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $444.16 |
| Revenue Next Year | N/A | $248.39 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.28 | $0.55 |
| 52 Week High | $9.34 | $2.93 |
Technical Indicators
Market Signals| Indicator | DOYU | HUMA |
|---|---|---|
| Relative Strength Index (RSI) | 44.74 | 57.98 |
| Support Level | $4.50 | $0.92 |
| Resistance Level | $4.98 | $1.28 |
| Average True Range (ATR) | 0.16 | 0.13 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 60.41 | 57.32 |
Price Performance
Historical ComparisonAbout DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.
About HUMA Humacyte Inc.
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.